The Smartphone Operated/Next-Generation Glucose Monitor Market is expected to grow at a 15.0 % CAGR during the forecast period for 2024-2031.
The high prevalence of diabetes, rising demand for cost-effective equipment, growing geriatric population, unhealthy diet, fast adoption of advanced technologies, increasing government funding for healthcare services, and the surging R&D activities to innovate smartphone medical applications are driving the growth of this market. The increasing outbreak of current COVID-19 forces the biopharma companies to develop rapid and efficient disease monitoring tools. Thus, boosting the opportunities for this market. However, the data accuracy issues related to the glucose monitor devices and the lack of awareness among the public about the advanced medical smartphone applications may restrain the growth of this market over the forecast period.
Market Segmentation
The smartphone-operated/next-generation glucose monitor market is classified based on components, applications, end-users, and region. The market is grouped into diabetes monitoring devices, tracking & diagnosis apps (ios and android based), and kit accessories by components. The diabetes monitoring device segment is anticipated to dominate this market over the forecast period owing to the high prevalence of diabetes worldwide. By applications, the market is divided into single-use and dual-use. Based on the end-users, the market is classified into home settings, hospitals & other healthcare settings, and other end users. Regionally, the market is catagorized into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
North America dominated the market in 2023 and is projected to dominate during the forecast period due to the growing incidence of diabetics, increasing demand for smartphone medical applications, and the rising government initiatives to advance healthcare services.
Competitive Landscape
Some Of The Key Players In The Smartphone Operated/Next-Generation Glucose Monitor Market:
- Health Arx Technologies Pvt. Ltd (India),
- myDario (US),
- iHealth Labs, Inc (US),
- KETO-MOJO (US),
- LifeScan IP Holdings, LLC (US),
- Ascensia Diabetes Care (Switzerland),
- Glooko, Inc (US),
- Dexcom, Inc (US),
- Roche Diabetes Care (US),
- ForeCare, Inc (US),
- Informed Data Sytems Inc (US),
- One Drop (US),
- Amanda Health Inc (US, Big Foot Medical Inc (US),
- Pops Diabetes Care Inc (US),
- HealthifyMe (Bengaluru),
- Intruity Medical, Inc (US),
- Health25ync (Taiwan),
- myDiabby Healthcare (France),
- Symbiome (US),
- Senseonics Holdings, Inc. (US),
- Diabnext (France),
- Diabeto Medtech India Pvt (India),
- Biosense Technology Pvt Ltd (India),
The Smartphone Operated/Next-Generation Glucose Monitor Market Report Scope
Report Attribute |
Specifications |
Market Size Value In 2023 |
USD XX Billion |
Revenue Forecast In 2031 |
USD XXBillion |
Growth Rate CAGR |
CAGR of 15.0% from 2024 to 2031 |
Quantitative Units |
Representation of revenue in US$ Billion and CAGR from 2024 to 2031 |
Historic Year |
2019 to 2023 |
Forecast Year |
2024-2031 |
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
Segments Covered |
By Components, By Application, By End-User |
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
Competitive Landscape |
Health Arx Technologies Pvt. Ltd (India), myDario (US), iHealth Labs, Inc (US), KETO-MOJO (US), LifeScan IP Holdings, LLC (US), Ascensia Diabetes Care (Switzerland), Glooko, Inc (US), Dexcom, Inc (US), Roche Diabetes Care (US), ForeCare, Inc (US), Informed Data Sytems Inc (US), One Drop (US), Amanda Health Inc (US, Big Foot Medical Inc (US), Pops Diabetes Care Inc (US), HealthifyMe (Bengaluru), Intruity Medical, Inc (US), Health25ync (Taiwan), myDiabby Healthcare (France), Symbiome (US), Senseonics Holdings, Inc. (US), Diabnext (France), Diabeto Medtech India Pvt (India), Biosense Technology Pvt Ltd (India), and others. |
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |